ADIAL PHARMACEUTICALS, INC. Quarterly Return On Assets in % from Q1 2019 to Q4 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Adial Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2019 to Q4 2023.
  • Adial Pharmaceuticals, Inc. Return On Assets for the quarter ending December 31, 2023 was -134 %, a 1% decline year-over-year.
  • Adial Pharmaceuticals, Inc. annual Return On Assets for 2023 was -134 %, a 1% decline from 2022.
  • Adial Pharmaceuticals, Inc. annual Return On Assets for 2022 was -133 %, a 40.9% increase from 2021.
  • Adial Pharmaceuticals, Inc. annual Return On Assets for 2021 was -224 %, a 49.9% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2023 -134 -1.33 -1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -149 +7.43 +4.75% Jul 1, 2023 Sep 30, 2023
Q2 2023 -147 +10.6 +6.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -180 -4.72 -2.69% Jan 1, 2023 Mar 31, 2023
Q4 2022 -133 +91.7 +40.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -157 +52.6 +25.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -158 +53.9 +25.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -175 -5.86 -3.46% Jan 1, 2022 Mar 31, 2022
Q4 2021 -224 -74.7 -49.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -209 -87.9 -72.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -212 -115 -120% Apr 1, 2021 Jun 30, 2021
Q1 2021 -169 -72.5 -74.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 -150 -63.8 -74.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -121 -36.8 -43.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -96.5 +78.2 +44.8% Apr 1, 2020 Jun 30, 2020
Q1 2020 -96.8 +154 +61.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 -86.1 Oct 1, 2019 Dec 31, 2019
Q3 2019 -84.5 Jul 1, 2019 Sep 30, 2019
Q2 2019 -175 Apr 1, 2019 Jun 30, 2019
Q1 2019 -251 Jan 1, 2019 Mar 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.